Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine

Name: Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine
Published: 2020
License: Public Domain

AB Biotek · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

immunity influenza microbiota saccharomyces-cerevisiae

immunity, vaccine reaction, influenza, covid19, cytokine storm, immunologic deficiency syndromes, trained immunity, vaccine adjuvant, covid-19, beta-glucans, saccharomyces cerevisiae, microbiota

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 851214
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.